Tag: Biosimilar

High retention rates after switching between infliximab biosimilars

Presented By
Dr Hafsah Nabi, Rigshospitalet, Denmar
Conference
ACR 2022
Type
News article

1 December 2022 14:21

ABP501 biosimilar for adalimumab: What you need to know

Presented By
Prof. Brian Kirby, St Vincent's Hospital, Dublin, Ireland
Conference
SPIN 2019
Type
Peer-reviewed article

21 June 2019 17:24

Switching infliximab biosimilars safe in treating chronic plaque psoriasis

Conference
SPIN 2019
Type
Peer-reviewed article

21 June 2019 16:26

Efficacy and safety of biosimilars

Trial
CONNECT-IBD and SPOSIB SB2
Conference
ECCO 2019
Type
Peer-reviewed article

9 May 2019 19:35
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com